Immunotherapy in genitourinary neoplasia.
Droller
M J
MJ
D000912:Antibodies, Neoplasm / Q000276:immunology; D000917:Antibody Formation; D001500:BCG Vaccine / Q000627:therapeutic use; D002292:Carcinoma, Renal Cell / Q000628:therapy; D002471:Cell Transformation, Neoplastic / Q000276:immunology; D005260:Female; D006801:Humans; D007111:Immunity, Cellular; D007116:Immunization, Passive; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000628:therapy; D008222:Lymphokines / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014165:Transfer Factor / Q000627:therapeutic use; D001749:Urinary Bladder Neoplasms / Q000628:therapy; D014565:Urogenital Neoplasms / Q000276:immunology / Q000628:therapy*; D014612:Vaccines / Q000008:administration & dosage
D000912:Antibodies, Neoplasm; D001500:BCG Vaccine; D008222:Lymphokines; D014165:Transfer Factor; D014612:Vaccines; D007372:Interferons